Skip to main content

Top navigation

  • Provider Resources
  • Contact Us
  • +1 844 396 7663
Bio-Techne Exosome logo

Main navigation

  • Physicians
    • ExoDx Prostate Test
    • Challenge of Prostate Cancer
    • Physician FAQs
    • What are Exosomes
    • Publications and Abstracts
  • Patients
    • The ExoDx Prostate Test
    • Understanding PSA Levels
    • About Prostate Cancer
    • Patient FAQs
    • Patient Assistance Program
    • Billing Information
  • Pharma Services
    • Working with Us
    • Biomarker Discovery
    • Assay Development
    • Exosome Enrichment Capabilities
    • Companion Diagnostics (CDx) and Clinical Trial Support
  • Our Technology
    • Our Technology
    • Sensitivity to RNA/DNA
    • Extraction Procedures
    • Superiority to cfDNA and CTCs
  • News & Events
    • Events
    • News
    • Press
    • Webinars

Top navigation

  • Provider Resources
  • Contact Us
  • +1 844 396 7663

Corporate Responsibility

ExosomeDx is now part of Bio-Techne.  Click here to learn more about Bio-Techne's corporate responsibility.

  • Bio-Techne Corporate Responsibility

(844) 396-7663
exosomedx.info@bio-techne.com
266 Second Ave, Suite 200
Waltham, MA 02451

Footer menu

  • About Bio-Techne
  • Management Team
  • Careers
  • Investors
  • Corporate Responsibility
  • Accreditation and Licensure

Social navigation

  • Twitter
  • LinkedIn

Iso LogoThis test was evaluated and its performance characteristics determined by Exosome Diagnostics, Inc. Exosome Diagnostics is certified under the Clinical Laboratory Improvement Amendments (CLIA) Act of 1988 as qualified to perform high complexity clinical testing. CLIA number: 22D2093470.  Exosome Diagnostics and ExoDx are registered trademarks of Exosome Diagnostics, Inc.

© 2020 ExoDx

Bottom footer navigation

  • Privacy Policy